The doctor, a professor of oncology at the Faculty of Medicine, Ain Shams, announced that a genetic analysis center will be opened, so that we know the genetic mutations present in each patient in order to determine the nature of the tumors present through them. This came during the launch of the 14th Conference on Breast and Women’s Tumors and Immunotherapy of Tumors, today, Tuesday, saying: We are happy to hold this event in Egypt, and to be Egyptian scientists on the map of scientific research in the treatment of tumors. Al-Ghazali explained that the research involved 15 parties.
Including the American Society of Oncology, the European Society of Surgical Oncology, and the International Society of Lung Oncology, with the participation of 200 scientists from around the world. Also read: The start of the “InternA professor of oncology at the Faculty of Medicine, Ain Shams, added: I am very happy with the cooperation in all of Egypt and the participation of all Egyptian medical associations and universities such as Ain Shams, Cairo, Al-Azhar and Assiut, and everyone related to diagnosis and treatment of tumors, along with distinguished professors and oncologists.ational Oncology” conference, with the participation of 12 international medical societies Al-Ghazali continued: The most important matter of this great gathering is the realization of science fiction and its transformation into reality in this conference, which we hope will have a great reflection on the Egyptian citizen. You may be interested: At the “International Oncology” conference: the launch of 5 new drugs for the treatment of cancer And the professor of oncology at the Faculty of Medicine, Ain Shams, continued: The topics of the conference are: the use of artificial intelligence for the first time in diagnosing breast and gynecological tumors; In order to reduce human error, as well as DNA analysis in the analysis of tumors, as well as the precise scientific detail of launching more than 5 new drugs in the treatment of tumors such as genetic, immunological and targeted therapies, and how we can give them for genetic analysis.